CLINICAL_TRIALS
trial_result
· 2026-01-15
Clinical Trial Update: REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant [Phase 2]
Summary
Phase 2 results from the REPOSE study evaluating suvorexant to reduce delirium by improving postoperative sleep in elderly patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Delirium in Old Age | Phase 2 | Status: COMPLETED | Results posted: 2026-01-15